{"schema_version":"1","generated_at":"2026-11-13T00:19:04.191Z","data_as_of":null,"url":"https://www.findmykol.com/kol/miki-garcia","json_url":"https://www.findmykol.com/kol/miki-garcia/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"miki-garcia","name":"Miki Garcia","credential":"MD","specialty":"Dermatology","specialty_raw":"Dermatology","therapeutic_area":"Dermatology","therapeutic_areas":["Dermatology"],"city":"Honolulu","state":"HI","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1265632194","openalex":"A5027130744"},"summary":"Miki Garcia is a Dermatology physician. OpenAlex indexes 11 publications with 511 citations (h-index 9).","overview":null,"focus":{"indications":[],"research_topics":["Dermatology"]},"scholarship":{"works_count":11,"cited_by_count":511,"h_index":9,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":22,"program_years":{"first":2021,"last":null},"rows_total":64,"shown":3,"withheld":61,"rows":[{"payer":"Botanix SB Inc","program_year":2025,"amount_usd":1000,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1265632194"},{"payer":"ABBVIE INC.","program_year":2025,"amount_usd":336.52,"payment_count":11,"source_url":"https://openpaymentsdata.cms.gov/search?query=1265632194"},{"payer":"Galderma Laboratories, L.P.","program_year":2025,"amount_usd":224.56,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1265632194"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1265632194","source":"payments"},"prescribing":{"data_year":2024,"areas_total":8,"areas_shown":3,"areas":[{"area":"Dermatology","share_pct":21.4,"classes_total":5,"classes":[{"class":"Corticosteroid","setting":"mixed","share_pct":9,"drugs":[{"name":"Triamcinolone Acetonide","share_pct":54.9},{"name":"Triamcinolone acetonide","share_pct":45.1}],"max_beneficiaries":27},{"class":"Interleukin-4 Receptor alpha Antagonist","setting":"prescribed","share_pct":3.5,"drugs":[{"name":"Dupixent Pen","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cancer & immunology","share_pct":21.2,"classes_total":5,"classes":[{"class":"Calcineurin inhibitor","setting":"prescribed","share_pct":8.8,"drugs":[{"name":"Tacrolimus","share_pct":100}],"max_beneficiaries":38},{"class":"Retinoid","setting":"prescribed","share_pct":4.4,"drugs":[{"name":"Tretinoin","share_pct":100}],"max_beneficiaries":14}]},{"area":"Respiratory","share_pct":14.9,"classes_total":3,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":8.3,"drugs":[{"name":"Mometasone Furoate","share_pct":100}],"max_beneficiaries":35},{"class":"RNA Synthetase Inhibitor Antibacterial","setting":"prescribed","share_pct":4.6,"drugs":[{"name":"Mupirocin","share_pct":100}],"max_beneficiaries":24}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":11,"shown":5,"withheld":6,"matched_by":"OpenAlex author record","recent":[{"title":"Effective Strategies for the Management of Pyoderma Gangrenosum: A Comprehensive Review","year":2015,"journal":"Acta Dermato Venereologica","source_url":"https://doi.org/10.2340/00015555-2008","status":"verified"},{"title":"100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: Results of a case series","year":2015,"journal":"Journal of the American Academy of Dermatology","source_url":"https://doi.org/10.1016/j.jaad.2015.06.060","status":"verified"},{"title":"Biologic Therapies in the Treatment of Psoriasis: A Comprehensive Evidence-Based Basic Science and Clinical Review and a Practical Guide to Tuberculosis Monitoring","year":2012,"journal":"Clinical Reviews in Allergy & Immunology","source_url":"https://doi.org/10.1007/s12016-012-8301-7","status":"verified"},{"title":"Effective Strategies for the Management of Pyoderma Gangrenosum","year":2012,"journal":"Advances in Wound Care","source_url":"https://doi.org/10.1089/wound.2011.0339","status":"verified"},{"title":"Hyperpigmented burn scar improved with a fractionated 1550 nm non-ablative laser","year":2012,"journal":"Dermatology Online Journal","source_url":"https://doi.org/10.5070/d396n5f8qn","status":"verified"}],"source":"works"},"contact":{"address_1":"1329 LUSITANA ST","address_2":"SUITE 109","city":"Honolulu","state":"HI","zip":"968132429","phone":"808-536-9888","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1265632194","source":"identity"},"similar":[{"name":"Robert Modlin","slug":"robert-modlin","institution":"University of California, Los Angeles","specialty":"Dermatology","url":"https://www.findmykol.com/kol/robert-modlin","json_url":"https://www.findmykol.com/kol/robert-modlin/profile.json"},{"name":"Andrew Blauvelt","slug":"andrew-blauvelt","institution":"University of Maryland School of Medicine","specialty":"Dermatology","url":"https://www.findmykol.com/kol/andrew-blauvelt","json_url":"https://www.findmykol.com/kol/andrew-blauvelt/profile.json"},{"name":"Jon Hanifin","slug":"jon-hanifin","institution":"Oregon Health & Science University (OHSU)","specialty":"Dermatology","url":"https://www.findmykol.com/kol/jon-hanifin","json_url":"https://www.findmykol.com/kol/jon-hanifin/profile.json"},{"name":"Heidi Kong","slug":"heidi-kong","institution":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","specialty":"Dermatology","url":"https://www.findmykol.com/kol/heidi-kong","json_url":"https://www.findmykol.com/kol/heidi-kong/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":61,"publications":6}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2011-06-27","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}